$AMBA

Young John Alexander sold $340K of AMBA

Young John Alexander (CFO) sold 5,033 shares of AMBARELLA INC (AMBA) at an average of $67.54 ($66.98–$67.87, $0.34M total) across 2 trades on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Young John Alexander
Published Jun 18, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

The disclosure confirms the CFO executed two open-market sale trades on 2026-06-17 totaling 5,033 shares at an average price of about $67.54, with holdings after the sale of 112,590 shares.

02

Market read

Traders may monitor insider activity, but 10b5-1 selling typically has limited predictive value for near-term fundamentals.

03

What to watch

The article does not state whether other insiders sold/bought around the same window, nor does it provide context on total insider ownership changes beyond the post-transaction holdings.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-18, disclosing sales executed 2026-06-17.

Background

This is an SEC Form 4 insider transaction for AMBARELLA, reported by the CFO.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

AMBARELLA CFO Young John Alexander sold about $339,946 of AMBA shares via an open-market sale under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived.

Evidence & confidence

The filing is a disclosed insider sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect liquidity planning rather than bearish fundamentals, so traders may ignore it.

Key entities

  • AMBARELLA INC

    US-listed company whose CFO insider sale is disclosed on Form 4.

  • Young John Alexander

    CFO who sold shares under a pre-arranged Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMBAMedAI 8/10

Ambarella Q2 Earnings Call Highlights

Ambarella (AMBA) announced a $50M stock buyback program. Q3 revenue forecasted at $115M-$124M, with IoT demand driving growth. Memory constraints may impact customers. Raised 5-year market forecast to $22.9B. Partnered with Capgemini and Macnica for indirect sales. X7 AI accelerator sampling for edge infrastructure.

$AMBAHigh

AMBARELLA INC (AMBA): Results of Operations and Financial Condition

AMBARELLA INC (AMBA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced second quarter fiscal 2027 financial results for the period ended Ju

$AMBAMedAI 8/10

Usain Bolt Just Got an AI Rival – Meet the Stocks Behind It

Unitree Robotics, a Chinese company, unveiled a humanoid robot 'Superman' claiming it runs faster than Usain Bolt. The company's IPO on the Shanghai Stock Exchange saw shares surge 460%, valuing it at $50 billion. Investors are betting on the humanoid robotics sector and its supply chain, including companies like Ambarella, Ouster, Cognex, Regal Rexnord, and Harmonic Drive Systems, which saw gains in July.